Tyvaso

Showing 1 posts of 1 posts found.

credit_rich_s

United Therapeutics terminates oral pulmonary arterial hypertension drug following Phase 3 failure

April 9, 2019
Manufacturing and Production, Research and Development Tyvaso, United Therapeutics, pharma, pulmonary arterial hypertension

United Therapeutics has revealed in a short announcement that, because its pulmonary arterial hypertension (PAH) therapy failed to meet its …

The Gateway to Local Adoption Series

Latest content